Treatment of single brain metastases

L. Gandola, P. Navarria, F. Lombardi

Research output: Contribution to journalArticle

Abstract

Brain metastases (BrM) occur in 30% to 50% of patients with malignant tumours and represent a relevant cause of morbidity and mortality. As documented by the extensive clinical use of magnetic resonance imaging with contrast enhancement, 25% to 35% of patients with BrM have a single localisation to the brain. Conventional therapeutic options for single BrM consist of either neurosurgery, or whole brain irradiation, or a combination of both. Treatment finality for the majority of the patients is palliation and life expectancy is in the order of a few months. In the last decade, the development of radiosurgery has represented an important advancement in the treatment of patients with BrM. This radiotherapeutic technique represents a possible non-invasive alternative to surgical exeresis for patients with lesions

Original languageEnglish
Pages (from-to)38-44
Number of pages7
JournalFORUM - Trends in Experimental and Clinical Medicine
Volume11
Issue number1
Publication statusPublished - 2001

Fingerprint

Neoplasm Metastasis
Brain
Therapeutics
Radiosurgery
Neurosurgery
Life Expectancy
Magnetic Resonance Imaging
Morbidity
Mortality
Neoplasms

Keywords

  • Neurosurgery
  • Radiosurgery
  • Single brain metastasis
  • Whole brain radiotherapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treatment of single brain metastases. / Gandola, L.; Navarria, P.; Lombardi, F.

In: FORUM - Trends in Experimental and Clinical Medicine, Vol. 11, No. 1, 2001, p. 38-44.

Research output: Contribution to journalArticle

@article{f28c3106bfc049389a550fef0887cfe9,
title = "Treatment of single brain metastases",
abstract = "Brain metastases (BrM) occur in 30{\%} to 50{\%} of patients with malignant tumours and represent a relevant cause of morbidity and mortality. As documented by the extensive clinical use of magnetic resonance imaging with contrast enhancement, 25{\%} to 35{\%} of patients with BrM have a single localisation to the brain. Conventional therapeutic options for single BrM consist of either neurosurgery, or whole brain irradiation, or a combination of both. Treatment finality for the majority of the patients is palliation and life expectancy is in the order of a few months. In the last decade, the development of radiosurgery has represented an important advancement in the treatment of patients with BrM. This radiotherapeutic technique represents a possible non-invasive alternative to surgical exeresis for patients with lesions",
keywords = "Neurosurgery, Radiosurgery, Single brain metastasis, Whole brain radiotherapy",
author = "L. Gandola and P. Navarria and F. Lombardi",
year = "2001",
language = "English",
volume = "11",
pages = "38--44",
journal = "FORUM - Trends in Experimental and Clinical Medicine",
issn = "1121-8142",
publisher = "Scuola superiore di oncologia e scienze biomediche",
number = "1",

}

TY - JOUR

T1 - Treatment of single brain metastases

AU - Gandola, L.

AU - Navarria, P.

AU - Lombardi, F.

PY - 2001

Y1 - 2001

N2 - Brain metastases (BrM) occur in 30% to 50% of patients with malignant tumours and represent a relevant cause of morbidity and mortality. As documented by the extensive clinical use of magnetic resonance imaging with contrast enhancement, 25% to 35% of patients with BrM have a single localisation to the brain. Conventional therapeutic options for single BrM consist of either neurosurgery, or whole brain irradiation, or a combination of both. Treatment finality for the majority of the patients is palliation and life expectancy is in the order of a few months. In the last decade, the development of radiosurgery has represented an important advancement in the treatment of patients with BrM. This radiotherapeutic technique represents a possible non-invasive alternative to surgical exeresis for patients with lesions

AB - Brain metastases (BrM) occur in 30% to 50% of patients with malignant tumours and represent a relevant cause of morbidity and mortality. As documented by the extensive clinical use of magnetic resonance imaging with contrast enhancement, 25% to 35% of patients with BrM have a single localisation to the brain. Conventional therapeutic options for single BrM consist of either neurosurgery, or whole brain irradiation, or a combination of both. Treatment finality for the majority of the patients is palliation and life expectancy is in the order of a few months. In the last decade, the development of radiosurgery has represented an important advancement in the treatment of patients with BrM. This radiotherapeutic technique represents a possible non-invasive alternative to surgical exeresis for patients with lesions

KW - Neurosurgery

KW - Radiosurgery

KW - Single brain metastasis

KW - Whole brain radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0035197034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035197034&partnerID=8YFLogxK

M3 - Article

C2 - 11734863

AN - SCOPUS:0035197034

VL - 11

SP - 38

EP - 44

JO - FORUM - Trends in Experimental and Clinical Medicine

JF - FORUM - Trends in Experimental and Clinical Medicine

SN - 1121-8142

IS - 1

ER -